Ara
Toplam kayıt 4, listelenen: 1-4
Geographical Variation In Therapy For Bloodstream Infections Due To Multidrug-Resistant Enterobacteriaceae: A Post-Hoc Analysis Of The Increment Study
(Elsevier Science Bv, 2017)
We describe regional differences in therapy for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Patients (n ...
A Multinational, Preregistered Cohort Study Of Beta-Lactam/Beta-Lactamase Inhibitor Combinations For Treatment Of Bloodstream Infections Due To Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae
(Amer Soc Microbiology, 2016)
The spread of extended-spectrum-beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is leading to increased carbapenem consumption. Alternatives to carbapenems need to be investigated. We investigated whether ...
Development And Validation Of The Increment-Esbl Predictive Score For Mortality In Patients With Bloodstream Infections Due To Extendedspectrum- Beta-Lactamase-Producing Enterobacteriaceae
(Oxford Univ Press, 2017)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a ...
Ertapenem For The Treatment Of Bloodstream Infections Due To Esbl-Producing Enterobacteriaceae: A Multinational Pre-Registered Cohort Study
(Oxford Univ Press, 2016)
Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other ...